Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (3279)	6/5/1998 11:10:00 PM
From: James Baker	Read Replies (2) \| Respond to of 9523

I have no trouble with the Med Letter info that you posted just that you did not read the piece correctly and post complete information. Via personal message I was provided with a quote from the Med Letter and when you go and re-read it you will notice that it states for "NON-penicillinase producing S aureus" PCN is an appropriate first choice drug. The trouble is that 90% of clinical isolates of S auress ARE penicillinase PRODUCING. I don't need to go read the Med Letter to know this very basic microbiology. James P. Baker, MD Pediatric Infectious Diseases